Michelle’s Story of Hope shares an inspiring brain cancer journey, support resources, and advocacy through the End Brain Cancer Initiative.
Michelle’s Story of Hope shares an inspiring brain cancer journey, support resources, and advocacy through the End Brain Cancer Initiative.
Discover the Exvade Monorail Device, an FDA Breakthrough technology for real-time glioblastoma tracking. Learn about the clinical trial.
The European Commission has approved VORANIGO (vorasidenib) for IDH-mutant gliomas, representing a significant advancement in targeted brain cancer therapy.
Testing for IDH1/IDH2 mutations helps doctors accurately diagnose certain types of brain tumors, particularly gliomas.
Patrick O’Donnell, recipient of the 2024 National HOPE Award has passed away at the age of 23 after a three-year battle with brain cancer.
Jazz Pharmaceuticals has announced the U.S. FDA's approval of Modeyso™ (dordaviprone), the first and only treatment for pediatric brain cancer.
Mark Cuban's Cost Plus Drug Company offers select brain cancer generic medications at a discounted price when compared to traditional pharmaceutical pricing.
Explore a Phase 2 clinical trial for Primary Central Nervous System Lymphoma (PCNSL). Learn about eligibility and enrollment details at EndBrainCancer.org.
Top tips for wearing the Optune Gio device from a GBM brain cancer patient.
What are Tumor Treating Fields and how are they used to treat GBM Brain cancer?
Discover brain cancer treatment options for 2025. Learn about clinical trials, personalized medicine, and patient advocacy from the End Brain Cancer Initiative.
The Musella Foundation has funding for patients wanting to enroll in the Expanded Access Program (EAP) for Gallium Maltolate (GaM) for recurrent Glioblastoma.